An evaluation of the vasodilation produced by mephentermine and certain other sympathomimetic amines.
D000818:Animals; D001158:Arteries / Q000187:drug effects; D001285:Atropine / Q000494:pharmacology; D001783:Blood Flow Velocity; D055598:Chemical Phenomena; D002621:Chemistry; D003913:Dextroamphetamine / Q000494:pharmacology; D004285:Dogs; D004809:Ephedrine / Q000494:pharmacology; D005263:Femoral Artery / Q000187:drug effects; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D008616:Mephentermine / Q000494:pharmacology*; D008638:Mesenteric Arteries / Q000187:drug effects; D008680:Metaraminol / Q000494:pharmacology; D008694:Methamphetamine / Q000494:pharmacology; D008774:Methylphenidate / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D005996:Nitroglycerin / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011169:Portal Vein / Q000187:drug effects; D011433:Propranolol / Q000494:pharmacology; D012039:Regional Blood Flow / Q000187:drug effects*; D012077:Renal Artery / Q000187:drug effects; D012110:Reserpine / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology*; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology*
D006634:Histamine H1 Antagonists; D013566:Sympathomimetics; D014665:Vasodilator Agents; D010643:Phenoxybenzamine; D008774:Methylphenidate; D008694:Methamphetamine; D001285:Atropine; D008680:Metaraminol; D012110:Reserpine; D011433:Propranolol; D005996:Nitroglycerin; D004809:Ephedrine; D007545:Isoproterenol; D008616:Mephentermine; D003913:Dextroamphetamine